Cidofovir on Hhv-8 in Bcbl-1 Cells

Antman K. , & Chang Y. Kaposi's sarcoma. New England Journal of Medicine 2002; 342: 1027–1038.

Kedes D.H. , & Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. Journal of Clinical Investigation 1997; 99: 2082–2086.

Neyts J. , & De Clercq E. Antiviral drug susceptibility of human herpes virus 8. Antimicrobial Agents & Chemotherapy 1997; 41: 2754–2756.

Fife K. , Gill J. , Bourboulia D. , Gazzard B. , Nelson M. , & Bower M. Cidofovir for the treatment of Kaposi's sarcoma in an HIV-negative homosexual man. British Journal of Dermatology 1999; 141: 1148–1150.

Mazzi R. , Parisi S.G. , Sarmati L. , Uccella I. , Nicastri E. , Carolo G. , Gatti F. , Concia E. , & Andreoni M. Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS. AIDS 1997; 15: 2061–2063.

Little R.F. , Merced-Galindez F. , Staskus K. , Whitby D. , Aoki Y. , Humphrey R. , Pluda J.M. , Marshall V. , Walters M. , Welles L. , Rodriguez-Chavez I.R. , Pittaluga S. , Tosato G. , & Yarchoan R. A pilot study of cidofovir in patients with Kaposi's sarcoma. Journal of Infectious Diseases 2003; 187: 149–153.

Simonart T. , Noel J.C. , De Dobbeleer G. , Parent D. , Van Vooren J.P. , De Clercq E. , & Snoeck R. Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: report of a case. Journal of Medical Virology 1998; 55: 215–218.

Pica F. , Volpi A. , Serafino A. , Fraschetti M. , Franzese O. , & Garaci E. Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells. Blood 2000; 95: 2905–2912.

Wachsman M. , Petty B.G. , Cundy K.C. , Jaffe H.S. , Fisher P.E. , Pastelak A. , & Lietman P.S. Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Research 1996; 29: 153–161.

Stamey F.R. , Patel M.M. , Halloway B.P. , & Pellett P.E. Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens. Journal of Clinical Microbiology 2001; 39: 3537–3540.

Said J.W. , Chien K. , Tasaka T. , & Koeffler P. Ultrastructural characterization of Human herpesvirus 8 (Kaposi's sarcoma associated herpesvirus) in Kaposi's sarcoma lesions: electron microscopy permits distinction from cytomegalovirus (CMV). Journal of Pathology 1997; 182: 273–281.

Irmiere A. , & Gibson W. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 1983; 130: 118–133.